The New Agilent Seahorse XF Flex Analyzer Takes Real Time Metabolic Analysis to the Third Dimension
Three-dimensional (3D) models offer significant benefits for biomedical research by providing a more realistic understanding of biological processes and diseases than traditional 2D methods. The webinar will present Agilent's latest innovation, the Seahorse XF Flex analyzer. This platform offers flexibility and an optimized workflow for functional metabolic studies in 3D models, including ex vivo tissue samples and organoids, pushing the boundaries of metabolic research.
Learning objectives:
- An introduction to the enhanced metabolic assay platform developed for applications using 3D study models.
- Techniques for optimizing assay performance with different sample types and data normalization options
- Guidance on selecting the appropriate consumables to ensure successful results
- Examples of how improved sensitivity and precision will help you to achieve high-quality data
Presenter: Natalia Romero, PhD (R&D Director, Agilent Technologies)
Dr. Natalia Romero is the research and development director of workflow development at the cell function & phenotyping business of Agilent Technologies, contributing to developing analytical life-science solutions for characterizing cell metabolism, phenotype, and function. Dr. Romero pursued her Ph.D. in Biochemistry at Universidad de la Republica, Uruguay, and conducted postdoctoral studies at the Brigham and Women’s Hospital - Harvard Medical School in mechanisms of redox signaling. In 2015, she joined Seahorse Technologies—now part of Agilent—where she has led the development of new assays to study bioenergetic metabolism using Seahorse XF technology. Dr. Romero has authored multiple peer-reviewed publications and book chapters and has contributed as an inventor in several patents.
